515 related articles for article (PubMed ID: 17261134)
1. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of TT virus infection in patients with chronic hepatitis C.
Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese.
Tanaka K; Hirohata T
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):238-48. PubMed ID: 9778916
[TBL] [Abstract][Full Text] [Related]
6. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
[TBL] [Abstract][Full Text] [Related]
8. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea.
Lee DS; Sung YC; Whang YS
J Med Virol; 1996 May; 49(1):55-60. PubMed ID: 8732860
[TBL] [Abstract][Full Text] [Related]
9. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b.
Zein NN; Poterucha JJ; Gross JB; Wiesner RH; Therneau TM; Gossard AA; Wendt NK; Mitchell PS; Germer JJ; Persing DH
Am J Gastroenterol; 1996 Dec; 91(12):2560-2. PubMed ID: 8946986
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
Lee CM; Lu SN; Hung CH; Tung WC; Wang JH; Tung HD; Chen CH; Hu TH; Changchien CS; Chen WJ
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):767-74. PubMed ID: 16443243
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
Benvegnù L; Pontisso P; Cavalletto D; Noventa F; Chemello L; Alberti A
Hepatology; 1997 Jan; 25(1):211-5. PubMed ID: 8985292
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt.
Ryu SH; Fan X; Xu Y; Elbaz T; Zekri AR; Abdelaziz AO; Di Bisceglie AM
J Med Virol; 2009 May; 81(5):844-7. PubMed ID: 19319951
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
[TBL] [Abstract][Full Text] [Related]
19. Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity.
Nakano I; Fukuda Y; Katano Y; Toyoda H; Hayashi K; Kumada T; Nakano S
J Med Virol; 2001 Sep; 65(1):45-51. PubMed ID: 11505442
[TBL] [Abstract][Full Text] [Related]
20. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma.
Sansonno D; Cornacchiulo V; Racanelli V; Dammacco F
Cancer; 1997 Jul; 80(1):22-33. PubMed ID: 9210705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
